🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Repligen Corporation

RGEN Healthcare
$163.81 $-6.48 (-3.81%)
Market Cap: $10.47 B
Gurus Holding
12
Popularity Rank
#276
% of Shares Held
4.29%
Net Activity (Q3 2026)
+$18.03 M

Guru Ownership Trend

Guru Analysis for Repligen Corporation (RGEN)

Repligen Corporation (RGEN), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 12 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $449.63 M.

Top institutional holders include Lee Ainslie and Andreas Halvorsen.

Institutional sentiment is currently Bullish. This is evidenced by a $18.03 M net inflow during the quarter.

Recent activity highlights Andreas Halvorsen who opened a new position. Conversely, Louis Moore Bacon reduced exposure by 37.7%.

Key Holders

Top 5 by Value

$272.48 M
$102.12 M
$46.52 M
$30.18 M
$28.82 M

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$136.68 M
Total Buy Value
New Buys 3
Additions 4
-$118.66 M
Total Sell Value
Reductions 3
Sold Out 1

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
4
Net Buyers
7

FAQs for Repligen Corporation (RGEN)

Major holders include Lee Ainslie ($272.48 M), Andreas Halvorsen ($102.12 M), Steven Cohen ($46.52 M). According to the latest reported data, 12 tracked investment managers collectively hold approximately 2.74 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $18.03 M, with 7 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited RGEN. The total reported sell value was $118.66 M.

Yes, 3 managers opened new positions in RGEN, and 4 increased their existing holdings. The total reported buy value was $136.68 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
2.13% Reduce -28.6% 1,417,489 $272.48 M Q3 2026
0.31% New Buy 531,227 $102.12 M Q3 2026
0.05% Add 45.6% 241,982 $46.52 M Q3 2026
0.28% Reduce -10.2% 156,976 $30.18 M Q3 2026
0.06% Add 5.1% 149,941 $28.82 M Q3 2026
0.07% New Buy 89,106 $17.13 M Q3 2026
0.33% 77,400 $14.88 M Q3 2026
0.54% 40,800 $7.84 M Q3 2026
0.09% Reduce -37.7% 23,397 $4.5 M Q3 2026
0.00% Add 22.9% 10,984 $2.11 M Q3 2026
0.01% New Buy 5,503 $1.06 M Q3 2026
0.00% Add 15.4% 15 $2,830 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form